Program Studies
GOLO conducted several pilot studies to demonstrate the safety and efficacy of the GOLO Program, which included dietary modification, nutraceutical supplementation, and regular exercise. Studies were conducted in both the United States and South Africa between 2009 and 2014, with consistent results observed across the studies. Study participants ranged between moderate to very overweight or obese participants, including some needing to lose in excess of 100 pounds.
The chart to the right shows the average weight loss results achieved by GOLO study participants, and the results that are possible by following the GOLO Program.
Click Here to see Efficacy of a Diet Program on Body Weight in Americans.
Click Here to see Pilot Studies on Overweight and Obese Individuals.
Click Here to see the Effect of the GOLO Diet and Release Supplement on Weight Related Factors.
Disclaimer: Pilot studies conducted were preliminary and did not include a placebo control. Study participants followed the entire GOLO program including the GOLO meal plan, Release supplementation, a recommendation of 15 minutes of daily exercise and were provided GOLO lifestyle modification recommendations. GOLO is not intended to diagnose, treat, cure or prevent any disease and has not been evaluated by the FDA. Consult your doctor before starting GOLO or any weight loss program and before reducing or eliminating any medications.
Sustainable weight loss doesn’t happen overnight, and that’s okay. Even small changes can have a huge effect on your health and energy. Gradual weight loss allows you to retain muscle and repair your metabolic health. Take a look at some of our study participant's transitions below to see that as you work towards your goal you will eventually be able to visibly recognize progress and proof of the positive changes that are happening over time.
Release is made in the USA at a FDA registered pharmaceutical facility which is NSF International, Health Canada, TGA and Organic certified and is only available through GOLO.
